Benzinga's Top #PreMarket Losers

ImmunoGen, Inc. IMGN shares dropped 45.30% to $5.94 after the company reported that Roche has provided an update on the MARIANNE trial. Finish Line Inc. FINL shares fell 12.80% to $25.20 on downbeat quarterly results. BlackBerry Limited BBRY slipped 8.24% to $9.24 in pre-market trading after the company reported Q3 results. Bellicum Pharmaceuticals, Inc BLCM declined 3.69% to $23 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!